RE:RE:RE:Bracelet OSIt was a randomised phase II trial, why does it need validation..? The whole point of showing statisical significance in a Phase II, is that you can then move straight to Phase III.
FDA gave ONCY fast track and SPA... but only advised them to find a biomarker... NOT insisted, or demanded.
So there was something fishy about the results, that no-one was prepared to cover the cost of a Phase III, when all ONCY had to do was repeat the same results on a larger patient population...
did they cherry pick patients..???
Watch Matt back in 2018 talk about running the phase III in 2019... and he says the same effin thing every year.. so since he's your God, and likes repeating ad nauseum, I'll follow his lead...
what a mess... there will be no partnership this year folks... don't let the pumpers fool you... the dog and pony show continues unabated.